Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7,59% | 150 K | 77,52% | 4,63% | 2042-10-01 | 67,49 M USD | 1 000,00 USD | 2 000,00 USD | Actavis, Inc. |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7,40% | 15 K | 79,63% | 4,85% | 2044-06-15 | 65,23 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,28% | 10 K | 79,20% | 4,75% | 2045-03-15 | 53,51 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AA5QDALLERGAN FNDG 15/25 | 7,15% | 0 | 99,26% | 3,80% | 2025-03-15 | 130,22 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6,75% | 72 K | 86,70% | 4,55% | 2035-03-15 | 107,65 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049 | 6,18% | 30 K | 81,05% | 4,25% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
US287YAW9ABBVIE 16/46 | 6,06% | 0 | 84,97% | 4,45% | 2046-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042 | 5,98% | 10 K | 86,35% | 4,40% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
4ABBABBVIE 15/45 | 5,95% | 0 | 88,48% | 4,70% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048 | 5,93% | 2,31 M | 89,55% | 4,88% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039 | 5,92% | 2 M | 85,18% | 4,05% | 2039-11-21 | 4 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044 | 5,91% | 20 K | 90,38% | 4,85% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042 | 5,90% | 2,3 M | 88,93% | 4,63% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064 | 5,82% | 1,03 M | 96,20% | 5,50% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054 | 5,78% | 1 M | 95,86% | 5,40% | 2054-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045 | 5,68% | 4,49 M | 91,21% | 4,75% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044 | 5,67% | 203 K | 97,04% | 5,35% | 2044-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
US287YAV1ABBVIE 16/36 | 5,56% | 0 | 91,23% | 4,30% | 2036-05-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
US287YAR0ABBVIE 15/35 | 5,48% | 0 | 93,50% | 4,50% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035 | 5,48% | 2 K | 93,92% | 4,55% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034 | 5,29% | 229 K | 98,52% | 5,05% | 2034-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029 | 5,10% | 20 K | 92,50% | 3,20% | 2029-11-21 | 62,52 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029 | 5,09% | 1,11 M | 92,57% | 3,20% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031 | 5,00% | 598 K | 99,74% | 4,95% | 2031-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
4ABCABBVIE 15/25 | 4,96% | 0 | 99,48% | 3,60% | 2025-05-14 | 3,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029 | 4,89% | 6,25 M | 99,70% | 4,80% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025 | 4,85% | 3,32 M | 99,77% | 3,80% | 2025-03-15 | 2,89 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028 | 4,79% | 235 K | 98,22% | 4,25% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
US287YAY5ABBVIE 16/26 | 4,66% | 0 | 98,09% | 3,20% | 2026-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026 | 4,63% | 514 K | 97,05% | 2,95% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027 | 4,61% | 3,24 M | 100,39% | 4,80% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
XS190919331ALLERGAN FNDG 18/28 | 4,11% | 0 | 95,03% | 2,63% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026 | 3,86% | 0 | 96,53% | 2,95% | 2026-11-21 | 9,24 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
XXS162262122ALLERGAN FNDG 17/29 | 3,80% | 0 | 93,63% | 2,13% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
4ABGABBVIE 19/31 | 3,02% | 0 | 89,86% | 1,25% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. |
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025 | 3,01% | 0 | 102,15% | 3,80% | 2025-03-15 | 1,27 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049 | 2,90% | 0 | 121,31% | 4,25% | 2049-11-21 | 4,95 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045 | 2,88% | 0 | 126,76% | 4,75% | 2045-03-15 | 5 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
XS152090781ABBVIE 16/28 | 2,84% | 0 | 97,49% | 2,13% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. |
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044 | 2,83% | 0 | 128,71% | 4,85% | 2044-06-15 | 100 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
XS212591483ABBVIE 20/28 | 2,76% | 0 | 99,52% | 2,63% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. |
XS212591491ABBVIE 20/29 | 2,76% | 0 | 97,49% | 2,13% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. |
4ABEABBVIE 19/27 | 2,64% | 0 | 94,91% | 0,75% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. |
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035 | 2,35% | 0 | 123,74% | 4,55% | 2035-03-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042 | — | — | — | 4,40% | 2042-11-06 | 1,1 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025 | — | — | — | 3,80% | 2025-03-15 | — | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |